|
|
Volumn 14, Issue 3, 2002, Pages 201-202
|
|
Chemoradiation: The new gold standard for non-surgical treatment of cervical cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CISPLATIN;
FLUOROURACIL;
PLATINUM;
ANTINEOPLASTIC AGENT;
ADVANCED CANCER;
ANEMIA;
BEAM THERAPY;
BLOOD TOXICITY;
BRACHYTHERAPY;
CANADA;
CANCER CHEMOTHERAPY;
CANCER CONTROL;
CANCER MORTALITY;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER SURVIVAL;
CLINICAL PRACTICE;
COCHRANE LIBRARY;
CONTROLLED STUDY;
DATA ANALYSIS;
EDITORIAL;
GASTROINTESTINAL TOXICITY;
HUMAN;
META ANALYSIS;
METASTASIS;
NORTH AMERICA;
PELVIS CANCER;
PRIORITY JOURNAL;
PROGNOSIS;
RADIATION DOSE;
SURVIVAL RATE;
UTERINE CERVIX CANCER;
FEMALE;
MULTIMODALITY CANCER THERAPY;
NOTE;
UTERINE CERVIX TUMOR;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
UTERINE CERVICAL NEOPLASMS;
|
|
EID: 0036594984
PISSN: 09366555
EISSN: None
Source Type: Journal
DOI: 10.1053/clon.2002.0093 Document Type: Editorial |
|
Times cited : (6)
|
|
References (4)
|
